Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 5:30 pm Purchase |
2022-01-12 | 13D | Fusion Pharmaceuticals Inc. FUSN |
TPG GP A, LLC | 2,621,436 6.100% |
2,621,436 (New Position) |
Filing History |
| 2021-02-10 4:02 pm Purchase |
2020-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Adams Street Partners, LLC | 3,492,749 8.400% |
3,492,749 (New Position) |
Filing History |
| 2021-02-09 4:10 pm Purchase |
2020-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
VARIAN MEDICAL SYSTEMS INC VAR |
3,256,972 7.810% |
3,256,972 (New Position) |
Filing History |
| 2021-02-08 10:23 am Purchase |
2021-02-05 | 13G | Fusion Pharmaceuticals Inc. FUSN |
FMR CORP | 3,129,434 7.499% |
3,129,434 (New Position) |
Filing History |
| 2021-02-03 6:37 pm Purchase |
2020-12-31 | 13G | Fusion Pharmaceuticals Inc. FUSN |
CANADA PENSION PLAN INVESTMENT BOARD | 3,116,966 7.500% |
3,116,966 (New Position) |
Filing History |
| 2020-07-23 1:32 pm Purchase |
2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN |
Seroba Life Sciences Management Ltd | 2,021,646 4.850% |
2,021,646 (New Position) |
Filing History |
| 2020-07-10 5:00 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
HealthCap VII L.P. | 3,807,247 9.100% |
3,807,247 (New Position) |
Filing History |
| 2020-07-10 4:37 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
TPG Group Holdings (SBS) Advisors Inc. | 2,621,436 6.300% |
2,621,436 (New Position) |
Filing History |
| 2020-07-06 5:57 pm Purchase |
2020-06-30 | 13D | Fusion Pharmaceuticals Inc. FUSN |
ORBIMED ADVISORS LLC | 2,997,981 7.200% |
2,997,981 (New Position) |
Filing History |
| 2020-07-02 6:21 pm Purchase |
2020-06-30 | 13G | Fusion Pharmaceuticals Inc. FUSN |
JOHNSON & JOHNSON JNJ |
3,759,634 9.000% |
3,759,634 (New Position) |
Filing History |